Advertisement

Molecular Biology Reports

, Volume 40, Issue 3, pp 2115–2125 | Cite as

Association of methylenetetrahydrofolate reductase gene 677C > T polymorphism and Down syndrome

  • Marcelo Aguiar Costa-Lima
  • Márcia Rodrigues Amorim
  • Iêda Maria OrioliEmail author
Article

Abstract

The association between Down syndrome (DS) and maternal polymorphisms in genes encoding folic acid metabolizing enzymes remains a controversial issue. A meta-analysis was performed to evaluate the association of maternal MTHFR 677C > T polymorphism and the risk of having a child with DS. Case–control studies were screened from major literature databases. Twenty articles from 13 countries worldwide, with a total of 2,101 DS and 2,702 control mothers, attended the inclusion criteria. We found a 50 % increase for the association of maternal homozygous TT genotype and DS in both fixed (OR = 1.51; 95 % CI 1.22–1.87) and random effects models (OR 1.54; 95 % 1.15–2.05). Similarly, a significant pooled OR was found for the heterozygote CT, with an OR 1.26; 95 % CI 1.10–1.43 (fixed effects model) and OR 1.28; 95 % 1.08–1.51 (random effects model). As ultra-violet B solar radiation highly depends on latitude, and can promote, in less pigmented skin, intravascular folate photolysis, we stratified the analysis by latitude region, defining as Tropical (between 23.5° S and 23.5° N), Sub-Tropical (between 23.5° and 40° N and S), and Northern (≥40o N). Significant association was only found for Sub-Tropical area, both using fixed and random effect models. In conclusion, MTHFR 677C > T polymorphism is a moderate risk factor for DS for some populations, and populations located in Sub-Tropical region seem to be at greater risk. Latitude, ethnicity, skin pigmentation, and red blood cell folate are important variables to be considered in future studies.

Keywords

Down syndrome risk MTHFR 677C > T Meta-analysis Latitude UVB Folate 

Notes

Acknowledgments

This study was supported by Grants from Fundação de Auxílio à Pesquisa do Estado do Rio de Janeiro, Brazil (E-26/110.427/2011; E-26/102.797/2012), and Conselho Nacional de Desenvolvimento e Pesquisa, Brazil (476978/2008-4; 308885/2006-6; 573993/2008-4).

Conflict of interest

None.

References

  1. 1.
    Epstein CJ (2001) Down syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease 8e. McGraw-Hill, New York, pp 1223–1256Google Scholar
  2. 2.
    Eskes TK (2006) Abnormal folate metabolism in mothers with Down syndrome offspring: review of the literature. Eur J Obstet Gynecol Reprod Biol 124:130–133PubMedCrossRefGoogle Scholar
  3. 3.
    Schupf N, Kapell D, Nightingale B, Lee JH, Mohlenhoff J, Bewley S, Ottman R, Mayeux R (2001) Specificity of the fivefold increase in AD in mothers of adults with Down syndrome. Neurology 57:979–984PubMedCrossRefGoogle Scholar
  4. 4.
    Guéant JL, Guéant-Rodriguez RM, Anello G, Bosco P, Brunaud L, Romano C, Ferri R, Romano A, Candito M, Namour B (2003) Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and Down syndrome? Clin Chem Lab Med 11:1473–1477Google Scholar
  5. 5.
    Yamada K, Chen Z, Rozen R, Matthews RG (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 98:14853–14858PubMedCrossRefGoogle Scholar
  6. 6.
    Ulvik A, Ueland PM, Fredriksen A, Meyer K, Vollset SE, Hoff G, Schneede J (2007) Functional inference of the methylenetetrahydrofolate reductase 677 C > T and 1298A > C polymorphisms from a large-scale epidemiological study. Hum Genet 121:57–64PubMedCrossRefGoogle Scholar
  7. 7.
    Rozen R (1996) Molecular genetics of methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis 19:589–594PubMedCrossRefGoogle Scholar
  8. 8.
    Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Oliviero O, Jacques PF, Rosenberg IH, Corrocher R, Selhub J (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99:5606–5611PubMedCrossRefGoogle Scholar
  9. 9.
    Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE (2001) Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22:195–201PubMedCrossRefGoogle Scholar
  10. 10.
    James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW (1999) Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70:495–501PubMedGoogle Scholar
  11. 11.
    Wang X, Thomas P, Xue J, Fenech M (2004) Folate deficiency induces aneuploidy in human lymphocytes in vitro-evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. Mutat Res 551:167–180PubMedCrossRefGoogle Scholar
  12. 12.
    Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R, James J (2000) Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 67:623–630PubMedCrossRefGoogle Scholar
  13. 13.
    Ueland PM, Refsum H, Christensen B (1990) Methotrexate sensitivity in Down’s syndrome: a hypothesis. Cancer Chemother Pharmacol 25:384–386PubMedCrossRefGoogle Scholar
  14. 14.
    Pogribna M, Melnyk S, Pogribny I, Chango A, Yi P, James SJ (2001) Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet 69:88–95PubMedCrossRefGoogle Scholar
  15. 15.
    Hobbs CA, Cleves MA, Lauer RM, Burns TL, James SJ (2002) Preferential transmission of the MTHFR 677 T allele to infants with Down syndrome: implications for a survival advantage. Am J Med Genet 113:9–14PubMedCrossRefGoogle Scholar
  16. 16.
    da Silva LRJ, Vergani N, Galdieri LC, Porto MPR, Longhitano SB, Brunoni D, D′Almeida V, Perez ABA (2005) Relationship between polymorphisms in genes involved in homocysteine metabolism and maternal risk for Down syndrome in Brazil. Am J Med Genet Part A 135A:263–267CrossRefGoogle Scholar
  17. 17.
    Rai AK, Singh S, Mehta S, Kumar A, Pandey LK, Raman R (2006) MTHFR 677C > T and A1298C polymorphisms are risk factors for Down’s syndrome in Indian mothers. J Hum Genet 51:278–283PubMedCrossRefGoogle Scholar
  18. 18.
    Wang SS, Qiao FY, Feng L, Lv JJ (2008) Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome in China. J Zhejiang Univ Sci B 9:93–99PubMedCrossRefGoogle Scholar
  19. 19.
    Meguid NA, Dardir AA, Khass M, Hossieny LE, Ezzat A, El Awady MK (2008) MTHFR genetic polymorphism as a risk factor in Egyptian mothers with Down syndrome children. Dis Markers 24:19–26PubMedGoogle Scholar
  20. 20.
    Brandalize AP, Bandinelli E, dos Santos PA, Roisenberg I, Schüler-Faccini L (2009) Evaluation of 677C > T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for Down syndrome and congenital heart defects. Am J Med Genet A 149A:2080–2087PubMedCrossRefGoogle Scholar
  21. 21.
    Sadiq MF, Al-Refai EA, Al-Nasser A, Khassawneh M, Al-Batayneh Q (2011) Methylenetetrahydrofolate reductase polymorphisms C677T and A1298C as maternal risk factors for Down syndrome in Jordan. Genet Test Mol Biomarker 15:1–7CrossRefGoogle Scholar
  22. 22.
    Stuppia L, Gatta V, Gaspari AR, Antonucci I, Morizio E, Calabrese G, Palka G (2002) C677T mutation in the 5,10-MTHFR gene and risk of Down syndrome in Italy. Eur J Hum Genet 10:388–390PubMedCrossRefGoogle Scholar
  23. 23.
    Boduroglu K, Alanay Y, Koldan B, Tuncbilek E (2004) Methylenetetrahydrofolate reductase enzyme polymorphisms as maternal risk for Down syndrome among Turkish women. Am J Med Genet 127A:5–10PubMedCrossRefGoogle Scholar
  24. 24.
    Chango A, Fillon-Emery N, Mircher C, Bléhaut H, Lambert D, Herbeth B, James SJ, Réthoré MO, Nicolas JP (2005) No association between common polymorphisms in genes of folate and homocysteine metabolism and the risk of Down’s syndrome among French mothers. Br J Nutr 94:166–169PubMedCrossRefGoogle Scholar
  25. 25.
    Martínez-Frías ML (2008) The biochemical structure and function of methylenetetrahydrofolate reductase provide the rationale to interpret the epidemiological results on the risk for infants with Down syndrome. Am J Med Genet Part A 146A:1477–1482PubMedCrossRefGoogle Scholar
  26. 26.
    Santos-Rebouças CB, Corrêa JC, Bonomo A, Fintelman-Rodrigues N, Moura KC, Rodrigues CS, Santos JM, Pimentel MM (2008) The impact of folate pathway polymorphisms combined to nutritional deficiency as a maternal predisposition factor for Down syndrome. Dis Markers 25:149–157PubMedGoogle Scholar
  27. 27.
    Pozzi E, Vergani P, Dalprá L, Combi R, Silvestri D, Crosti F, Dell Orto M, Valsecchi MG (2009) Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome. Am J Obstet Gynecol 200:e1–e6 Epub 2009 Feb 28PubMedCrossRefGoogle Scholar
  28. 28.
    Vraneković J, Babić Bozović I, Starcević Cizmarević N, Buretić-Tomljanović A, Ristić S, Petrović O, Kapović M, Brajenović-Milić B (2010) Functional inference of methylenetetrahydrofolate reductase gene polymorphisms on enzyme stability as a potential risk factor for Down syndrome in Croatia. Dis Markers 28:293–298PubMedGoogle Scholar
  29. 29.
    O’Leary VB, Parle-McDermott A, Molloy AM, Kirke PN, Johnson Z, Conley M, Scott JM, Mills JL (2002) MTRR and MTHFR polymorphism: link to Down syndrome? Am J Med Genet 107:151–155PubMedCrossRefGoogle Scholar
  30. 30.
    Acácio GL, Barini R, Bertuzzo CS, Couto EC, Annichino-Bizzacchi JM, Júnior WP (2005) Methylenetetrahydrofolate reductase gene polymorphisms and their association with trisomy 21. Prenat Diagn 25:1196–1199PubMedCrossRefGoogle Scholar
  31. 31.
    Biselli JM, Goloni-Bertollo EM, Zampieri BL, Haddad R, Eberlin MN, Pavarino-Bertelli EC (2008) Genetic polymorphisms involved in folate metabolism and elevated plasma concentrations of homocysteine: maternal risk factors for Down syndrome in Brazil. Genet Mol Res 7:33–42PubMedCrossRefGoogle Scholar
  32. 32.
    Coppedè F, Migheli F, Bargagna S, Siciliano G, Antonucci I, Stuppia L, Palka G, Migliore L (2009) Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring. Neurosci Lett 449:15–19PubMedCrossRefGoogle Scholar
  33. 33.
    Kohli U, Arora S, Kabra M, Ramakrishnan L, Gulati S, Pandey RM (2008) Prevalence of MTHFR 677C > T polymorphism in north Indian mothers having babies with Trisomy 21 Down syndrome. Downs Syndr Res Pract 12:133–137PubMedCrossRefGoogle Scholar
  34. 34.
    Zintzaras E (2007) Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis. J Hum Genet 52:943–953PubMedCrossRefGoogle Scholar
  35. 35.
    Botto LD, Yang Q (2000) 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862–877PubMedCrossRefGoogle Scholar
  36. 36.
    Amorim MR, Costa Lima MA, Castilla EE, Orioli IM (2007) Non Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C > T: a meta-analysis. Am J Med Genet Part A 143A:1726–1732PubMedCrossRefGoogle Scholar
  37. 37.
    Clarke R, Bennett DA, Parish S, Verhoef P, Dötsch-Klerk M, Lathrop M, Xu P, Nordestgaard BG, Holm H, Hopewell JC, Saleheen D, Tanaka T, Anand SS, Chambers JC, Kleber ME, Ouwehand WH, Yamada Y, Elbers C, Peters B, Stewart AF, Reilly MM, Thorand B, Yusuf S, Engert JC, Assimes TL, Kooner J, Danesh J, Watkins H, Samani NJ, Collins R, Peto R (2012) MTHFR Studies Collaborative Group. Homocysteine and coronary heart disease: meta-analysis of MTHFR case–control studies, avoiding publication bias. PLoS Med 9:e1001177 Epub 2012 Feb 21PubMedCrossRefGoogle Scholar
  38. 38.
    Zintzaras E, Doxani C, Rodopoulou P, Bakalos G, Ziogas DC, Ziakas P, Voulgarelis M (2012) Variants of the MTHFR gene and susceptibility to acute lymphoblastic leukemia in children: a synthesis of genetic association studies. Cancer Epidemiol 36:169–176PubMedCrossRefGoogle Scholar
  39. 39.
    Jablonski NG, Chaplin G (2000) The evolution of human skin coloration. J Hum Evol 39:57–106PubMedCrossRefGoogle Scholar
  40. 40.
    Jablonski NG (1992) Sun, skin colour and spina bifida: an exploration of the relationship between ultraviolet light and neural tube defects. Proc Australas Soc Hum Biol 5:455–462Google Scholar
  41. 41.
    Jablonski NG (1999) A possible link between neural tube defects and ultraviolet light exposure. Med Hypotheses 52:581–582PubMedCrossRefGoogle Scholar
  42. 42.
    Chaplin G, Jablonski NG (1999) Vitamin D and the evolution of human depigmentation. Am J Phys Anthropol 139:451–461CrossRefGoogle Scholar
  43. 43.
    Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Mathews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113PubMedCrossRefGoogle Scholar
  44. 44.
    Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129CrossRefGoogle Scholar
  45. 45.
    Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMedCrossRefGoogle Scholar
  46. 46.
    Jablonski NG, Chaplin G (2010) Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proc Natl Acad Sci USA 107(Suppl 2):8962–8968PubMedCrossRefGoogle Scholar
  47. 47.
    Johnson FS, Mo T, Green AES (1976) Average latitudinal variation in ultraviolet radiation at the Earth’s surface. Photochem Photobiol 23:179–188PubMedCrossRefGoogle Scholar
  48. 48.
    Wang W, Xie W, Wang X (2007) The relationship between polymorphism of gene involved in folate metabolism, homocysteine level and risk of Down syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24:533–537PubMedGoogle Scholar
  49. 49.
    Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Gueant JLl (2003) Methionine synthase (MTR) 2756 (A - > G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet 121A:219–224PubMedCrossRefGoogle Scholar
  50. 50.
    Sheth JJ, Sheth FJ (2003) Gene polymorphism and folate metabolism: a maternal risk factor for Down syndrome. Indian Pediatr 40:115–123PubMedGoogle Scholar
  51. 51.
    Takamura N, Kondoh T, Ohgi S, Arisawa K, Mine M, Yamashita S, Aoyagi K (2004) Abnormal folic acid-homocysteine metabolism as maternal risk factors for Down syndrome in Japan. Eur J Nutr 43:285–287PubMedCrossRefGoogle Scholar
  52. 52.
    Grillo LB, Acacio GL, Barini R, Pinto W Jr, Bertuzzo CS (2002) Mutations in the methylene-tetrahydrofolate reductase gene and Down syndrome. Cad Saude Publica 18:1795–1797PubMedCrossRefGoogle Scholar
  53. 53.
    Chadefaux-Vekemans B, Coude M, Muller F, Oury JF, Chabli A, Jais JP, Kamoun P (2002) Methylenetetrahydrofolate reductase polymorphism in the etiology of Down syndrome. Pediatr Res 51:766–767PubMedCrossRefGoogle Scholar
  54. 54.
    Kokotas H, Grigoriadou M, Mikkelsen M, Giannoulia-Karantana A, Petersen MB (2009) Investigating the impact of the Down syndrome related common MTHFR 677C > T polymorphism in the Danish population. Dis Markers 27:279–285PubMedGoogle Scholar
  55. 55.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRefGoogle Scholar
  56. 56.
    Scala I, Granese B, Sellitto M, Salomè S, Sammartino A, Pepe A, Mastroiacovo P, Sebastio G, Andria G (2006) Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring. Genet Med 8:409–416PubMedCrossRefGoogle Scholar
  57. 57.
    Scala I, Granese B, Lisi A, Mastroiacovo P, Andria G (2007) Response to folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women. Am J Med Genet Part A 143A:1015–1017PubMedCrossRefGoogle Scholar
  58. 58.
    Narayanan DL, Saladi RN, Fox JL (2010) Ultraviolet radiation and skin cancer. Int J Dermatol 49:978–986PubMedCrossRefGoogle Scholar
  59. 59.
    Schuch AP, Yagura T, Makita K, Yamamoto H, Schuch NJ, Agnez-Lima LF, Macmahon RM, Menck CF (2012) DNA damage profiles induced by sunlight at different latitudes. Environ Mol Mutagen. doi: 10.1002/em.21678 PubMedGoogle Scholar
  60. 60.
    Chaplin G, Jablonski NG (1998) Hemispheric difference in human skin color. Am J Phys Anthropol 107:221–223PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Marcelo Aguiar Costa-Lima
    • 1
  • Márcia Rodrigues Amorim
    • 2
  • Iêda Maria Orioli
    • 3
    • 4
    Email author
  1. 1.Departamento de Genética, Instituto de Biologia Roberto Alcântara GomesUniversidade do Estado do Rio de JaneiroRio de JaneiroBrazil
  2. 2.Departamento de Biologia Geral, Instituto de BiologiaUniversidade Federal FluminenseRio de JaneiroBrazil
  3. 3.ECLAMC (Estudo Colaborativo Latino Americano de Malformações Congênitas) at Departamento de Genética, Instituto de BiologiaUniversidade Federal do Rio de JaneiroRio de JaneiroBrazil
  4. 4.INAGEMP (Instituto Nacional de Genética Médica Populacional)Rio de JaneiroBrazil

Personalised recommendations